Independent Advisor Alliance’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.96M Sell
21,612
-528
-2% -$44.2K 0.05% 284
2026
Q1
$1.77M Sell
22,140
-235
-1% -$19.4K 0.02% 598
2025
Q4
$1.91M Buy
22,375
+4,548
+26% +$373K 0.05% 315
2025
Q3
$1.39M Buy
17,827
+9,522
+115% +$744K 0.04% 369
2025
Q2
$650K Buy
8,305
+3,168
+62% +$236K 0.02% 510
2025
Q1
$372K Buy
5,137
+90
+2% +$6.44K 0.01% 597
2024
Q4
$374K Buy
+5,047
New +$353K ﹤0.01% 1049
2024
Q3
– Sell
-2,931
Closed -$271K – 726
2024
Q2
$271K Buy
+2,931
New +$260K 0.01% 594

Other funds holding EW

Independent Advisor Alliance's EW Position: Q2 2026 in Review

Independent Advisor Alliance reduced its Edwards Lifesciences (EW) stake by 2.4% in Q2 2026, selling an estimated $44.2K and leaving 21,612 shares worth $1.96M. The position accounts for 0.05% of the portfolio, ranked #284.

Independent Advisor Alliance first reported a position in EW in Q2 2024 and has held it in 8 quarters since. 1,338 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • Independent Advisor Alliance held 21,612 shares of Edwards Lifesciences worth $1.96M as of Q2 2026.
  • Independent Advisor Alliance sold 528 Edwards Lifesciences shares in Q2 2026, an estimated $44.2K.
  • Edwards Lifesciences made up 0.05% of Independent Advisor Alliance's portfolio in Q2 2026, its #284 holding.
  • Independent Advisor Alliance first reported a position in Edwards Lifesciences in Q2 2024 and has held it in 8 quarters since.
  • 1,338 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Independent Advisor Alliance's 13F filing for Q2 2026, filed 12 Aug 2026.